Difference between revisions of "Post-tPA Hemorrhage in CVA"

(Text replacement - "==References== " to "==References== <references/> ")
 
(8 intermediate revisions by 5 users not shown)
Line 1: Line 1:
*Consider if decreased LOC, increased weakness, new headache, sudden rise in blood pressure
+
==Background==
*If bleeding occurs after tPA:
+
*Consider if patient develops:
*Stop tpa infusion
+
**Decreased LOC
*Stat head CT
+
**Increased weakness
**If no bleeding: resume tpa
+
**New headache
 +
**Sudden rise in BP
 +
 
 +
==Management==
 +
*Stop tPA
 +
*Head CT
 +
**If no bleeding: resume tPA
 
**If bleeding:
 
**If bleeding:
 
***Consider fibrinogen replacement  
 
***Consider fibrinogen replacement  
***Recheck pt/ptt, platelets, fibrinogen levels
+
***Recheck CBC, coags fibrinogen levels
 
***Prepare 6-8 units cryoprecipitate
 
***Prepare 6-8 units cryoprecipitate
 
***Prepare 6-8 units platelets
 
***Prepare 6-8 units platelets
Line 14: Line 20:
 
*[[CVA (Main)]]
 
*[[CVA (Main)]]
  
==Source==
+
==References==
6/06 MISTRY
+
<references/>
 
+
[[Category:Neurology]]
[[Category:Neuro]]
 

Latest revision as of 01:13, 24 July 2017

Background

  • Consider if patient develops:
    • Decreased LOC
    • Increased weakness
    • New headache
    • Sudden rise in BP

Management

  • Stop tPA
  • Head CT
    • If no bleeding: resume tPA
    • If bleeding:
      • Consider fibrinogen replacement
      • Recheck CBC, coags fibrinogen levels
      • Prepare 6-8 units cryoprecipitate
      • Prepare 6-8 units platelets

See Also

References